← 產業報告目錄
Monkeypox Vaccine And Treatment Market Size, Share & Trends Analysis Report By Product (Vaccine, Drugs, Vaccinia Immune Globulin (VIG)), By Gender (Male, Female, Others), By Route of Administration, By End-Use, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-24頁數 180報告編號 INSIGHTACE-5d7bc2ed93
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the Monkeypox Vaccine And Treatment Market globally will surge at a 12.39% CAGR during 2024–2031.
Monkeypox Vaccine And Treatment encompasses key industry insights & findings from the report:
Increase in the prevalence of monkeypox is driving the monkeypox vaccine and treatment market. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is supported by surging healthcare spending, technological evolution, and the surging focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Monkeypox Vaccine and Treatment Market Snapshot
Chapter 4. Global Monkeypox Vaccine and Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Vaccine
5.2.1.1. JYNNEOS/ Imvanex
5.2.1.2. Smallpox Vaccine
5.2.1.3. Others
5.2.2. Drugs
5.2.2.1. Tecovirimat
5.2.2.2. Brincidofovir
5.2.2.3. Cidofovir
5.2.2.4. Others
5.2.3. Vaccinia Immune Globulin (VIG)
Chapter 6. Market Segmentation 2: by Gender Estimates & Trend Analysis
6.1. by Gender & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Gender:
6.2.1. Male
6.2.2. Female
6.2.3. Others
Chapter 7. Market Segmentation 3: by Route of Administration Estimates & Trend Analysis
7.1. by Route of Administration & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
7.2.1. Oral
7.2.2. Injectable
Chapter 8. Market Segmentation 4: by End-use Estimates & Trend Analysis
8.1. by End-use & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-use:
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Others
Chapter 9. Monkeypox Vaccine and Treatment Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Monkeypox Vaccine and Treatment Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
9.1.2. North America Monkeypox Vaccine and Treatment Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
9.1.3. North America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
9.1.4. North America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by End-use, 2024-2031
9.1.5. North America Monkeypox Vaccine and Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
9.2. Europe
9.2.1. Europe Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Product Type, 2024-2031
9.2.2. Europe Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Gender, 2024-2031
9.2.3. Europe Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
9.2.4. Europe Monkeypox Vaccine and Treatment Market revenue (US$ Million) by End-use, 2024-2031
9.2.5. Europe Monkeypox Vaccine and Treatment Market revenue (US$ Million) by country, 2024-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Product Type, 2024-2031
9.3.2. Asia Pacific Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Gender, 2024-2031
9.3.3. Asia-Pacific Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
9.3.4. Asia-Pacific Monkeypox Vaccine and Treatment Market revenue (US$ Million) by End-use, 2024-2031
9.3.5. Asia Pacific Monkeypox Vaccine and Treatment Market revenue (US$ Million) by country, 2024-2031
9.4. Latin America
9.4.1. Latin America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Product Type, 2024-2031
9.4.2. Latin America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Gender, 2024-2031
9.4.3. Latin America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
9.4.4. Latin America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by End-use, 2024-2031
9.4.5. Latin America Monkeypox Vaccine and Treatment Market revenue (US$ Million) by country, 2024-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Product Type, 2024-2031
9.5.2. Middle East & Africa Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Gender, 2024-2031
9.5.3. Middle East & Africa Monkeypox Vaccine and Treatment Market revenue (US$ Million) by Route of Administration, 2024-2031
9.5.4. Middle East & Africa Monkeypox Vaccine and Treatment Market revenue (US$ Million) by End-use, 2024-2031
9.5.5. Middle East & Africa Monkeypox Vaccine and Treatment Market revenue (US$ Million) by country, 2024-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Bavarian Noric
10.2.2. SIGA Technologies
10.2.3. Chimerix
10.2.4. EMERGENT
10.2.5. Gilead Sciences, Inc
10.2.6. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們